Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ […]
Brokerages predict that Vaxxinity, Inc. (NASDAQ:VAXX – Get Rating) will announce earnings of ($0.34) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Vaxxinity’s earnings, with the lowest EPS estimate coming in at ($0.36) and the highest estimate coming in at ($0.32). The company is expected to issue […]
Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ Vaxxinity […]
Shares of Vaxxinity Inc (NASDAQ:VAXX – Get Rating) gapped down before the market opened on Friday . The stock had previously closed at $4.40, but opened at $4.30. Vaxxinity shares last traded at $4.30, with a volume of 1,103 shares changing hands. VAXX has been the subject of a number of research reports. Zacks Investment […]